[1] Williams J D，Craig K J，Topley N，et al. Morphologic changes in the peritoneal membrane of patients with renal disease[J]. J Am Soc Nephrol， 2002， 13（2）： 470-479.
[2] M T Abdel Aziz ，H M Atta，S Mahfouz，et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis [J]. Clin Biochem， 2007， 40（12）： 893-899.
[3] A J Friedenstein，J F Gorskaja，Kulagina N N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs [J]. Exp Hematol， 1976， 4（5）： 267-274.
[4] Lazarus Hm，Haynesworth Se，Gerson Sl，et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use.[J]. Bone Marrow Transplant， 1995， 16（4）： 557-564.
[5] Pittenger M F，Mackay A M，Beck S C，et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science， 1999， 284（5411）： 143-147.
[6] Eisenberg L M，Eisenberg C A. Stem cell plasticity, cell fusion, and transdifferentiation[J]. Birth Defects Res C Embryo Today， 2003， 69（3）： 209-218.
[7] Yu Pei Fan，Ching Chih Hsia，Kuang Wen Tseng，et al. The therapeutic potential of human umbilical mesenchymal stem cells from wharton's jelly in the treatment of rat peritoneal dialysis-induced fibrosis [J]. Stem Cells Transl Med， 2016， 5（2）： 235-247.
[8] Chen K-S，Wang C-H，Yen T-H，et al. Potential role of bone marrow-derived cells in the turnover of mesothelium[J]. Renal failure， 2010， 32（9）： 1081-1087.
[9] Sekiguchi Y，Hamada C，Ro Y，et al. Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model[J]. Journal of Artificial Organs， 2012， 15（3）： 272-282.
[10] Yoshitaka I，Spees J L，Claudia S，et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment[J]. Biochemical & Biophysical Research Communications， 2007， 354（3）： 700-706.
[11] Premal T，Nancy T，Thuy N，et al. Mesenchymal stem cell therapy for treatment of cardiovascular disease: Helping people sooner or later[J]. Stem Cells & Development， 2010， 19（7）： 1109-1120.
[12] Caplan A I，Dennis J E. Mesenchymal stem cells as trophic mediators [J]. Journal of Cellular Biochemistry， 2006， 98（5）： 1076-1084.
[13] Ueno T，Nakashima A，Doi S，et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting tgf-β1 signaling[B]. Book， 2013， 84： 297-307.
[14] Takahashi M，Li Ts，Suzuki R，et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury[J]. Am J Physiol Heart Circ Physiol， 2006， 291（2）： H886-893.
[15] Wang N，Li Q，Zhang L，et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of tsg-6[J]. Plos One， 2012， 7（8）： e43768.
[16] Hosoon C，Ryang Hwa L，Nikolay B，et al. Anti-inflammatory protein tsg-6 secreted by activated mscs attenuates zymosan-induced mouse peritonitis by decreasing tlr2/nf-κb signaling in resident macrophages[J]. Blood， 2011， 118（2）： 330-338.
[17] Jayne L，István G，Mahoney D J，et al. Tsg-6 modulates the interaction between hyaluronan and cell surface cd44[J]. Journal of Biological Chemistry， 2004， 279（24）： 25745-25754.
[18] Akiyoshi H，Kawamura Y I，Masato Y，et al. Inhibition of ccl1-ccr8 interaction prevents aggregation of macrophages and development of peritoneal adhesions[J]. Journal of Immunology， 2007， 178（8）： 5296-5304.
[19] Yoshizawa H，Morishita Y，Watanabe M，et al. Tgf-β?-sirna delivery with nanoparticles inhibits peritoneal fibrosis.[J]. Gene Ther， 2015， 22（4）： 333-340.
[20] Loureiro J，Aguilera A，Selgas R，et al. Blocking tgf-β1 protects the peritoneal membrane from dialysate-induced damage[J]. J Am Soc Nephrol， 2011， 22（9）： 1682-1695.
[21] Tulpar S，Poyrazoglu M H，Ozbilge H，et al. Modulation of inflammation by mesenchymal stem cell transplantation in peritoneal dialysis in rats[J]. Ren Fail， 2012， 34（10）： 1317-1323.
[22] Shukla Mn，Rose Jl，Ray R，et al. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via smad7[J]. Am J Respir Cell Mol Biol， 2009， 40（6）： 643-653.
[23] Nakamura S，Niwa T. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage[J]. J Am Soc Nephrol， 2005， 16（1）： 144-150.
[24] Kim H，Mizuno M，Furuhashi K，et al. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation[J]. Cytotherapy， 2014， 16（3）： 357-368.
[25] Xiao Gh，Jeffers M，Bellacosa A，et al. Anti-apoptotic signaling by hepatocyte growth factor/met via the phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways[J]. Proc Natl Acad Sci U S A， 2001， 98（1）： 247-252.
[26] Ferdin J，Kunej T，Ga. C. Non-coding rnas: Identification of cancer-associated micrornas by gene profiling[J]. Technol Cancer Res Treat， 2010， 9（2）： 123-138.
[27] Zhou Q，Yang M，Lan H，et al. Mir-30a negatively regulates tgf-β1–induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting snai1[J]. American Journal of Pathology， 2013， 183（3）： 808-819.
[28] Yu J W，Duan W-J，Huang X-R，et al. Microrna-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis[J]. Laboratory Investigation， 2014， 94（9）： 978-990.
[29] Xiao L，Zhou X，Liu F，et al. Microrna-129-5p modulates epithelial-to-mesenchymal transition by targeting sip1 and sox4 during peritoneal dialysis[J]. Laboratory Investigation， 2015， 95（7）： 817-832.
[30] Li D，Lu Z，Li X，et al. Human umbilical cord mesenchymal stem cells facilitate the up-regulation of mir-153-3p, whereby attenuating mgo-induced peritoneal fibrosis in rats[J]. J Cell Mol Med， 2018， 22（7）： 3452-3463
[31] Ba?tu? F，Gündüz Z，Tülpar S，et al. Compare the effects of intravenous and intraperitoneal mesenchymal stem cell transplantation on ultrafiltration failure in a rat model of chronic peritoneal dialysis[J]. Chinese Hydraulics & Pneumatics， 2011， 15（1）： 11-15.
[32] Kunter U，Rong S，Boor P，et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes[J]. Journal of the American Society of Nephrology， 2007， 18（6）： 1754-1764.
[33] Lee Rh，Pulin Aa，Seo Mj，et al. Intravenous hmscs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein tsg-6[J]. Cell Stem Cell.， 2009， 5（1）： 54-63.
[34] Tolar J，Nauta A J，Osborn M J，et al. Sarcoma derived from cultured mesenchymal stem cells[J]. Stem Cells， 2007， 25（2）： 371-379.
[35] Alatab S，Shekarchian S，Najafi I，et al. Systemic infusion of autologous adipose tissue-derived mesenchymal stem cells in peritoneal dialysis patients: Feasibility and safety[J]. Cell Journal， 2018， 20（4）： 483-495.
[36] Shimomura Y，Sakai S，Ueda H，et al. Encapsulating peritoneal sclerosis in a patient after allogeneic hematopoietic stem cell transplantation: A case report[J]. BMC Gastroenterology， 2019， 19（1）： 12.
